HomeNews

News

Global Markets

Takeda Pharmaceutical expected fourth-quarter net income to decline

Pharma -
Takeda is expected to post a 92% drop in net profit from a year earlier to 15.96 billion yen ($122.3 million) for the quarter...
Regulatory

Lupin receives two FDA approvals and share price jumps

Pharma -
Global pharma major Lupin Ltd, May 06th, announced that it has received approval from the United States Food and Drug Administration (FDA) for its...
Global Markets

Clovis Oncology shares plummeted this week

Pharma -
Following the release of its first-quarter results and operational update, Clovis Oncology's shares traded down sharply. According to data provided by S&P Global Market...
Global Markets

Biogen invests $120 million in MedRhythms, a music therapy for multiple sclerosis

Pharma -
Biogen Inc. and MedRhythms have entered into a license agreement to develop and commercialize MR-004, an investigational prescription digital therapeutic for the potential treatment...
Global Markets

PepGen announces pricing of initial public stock offering

Pharma -
PepGen, Inc., a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with the goal of transforming the treatment of severe neuromuscular and...
Regulatory

FDA restricts J&J’s COVID-19 vaccine on blood clot risks

Pharma -
The Food and Drug Administration is limiting the use of the J&J shot, which received U.S. clearance in February 2021. In a statement released on...
1...313233...118Page 32 of 118
spot_img

Expert Articles

spot_img